Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19
Phase 1
Withdrawn
- Conditions
- Cytokine StormAcute Respiratory Distress SyndromeCOVID-19
- Interventions
- First Posted Date
- 2020-05-07
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Aveni Foundation
- Registration Number
- NCT04378244
BLESSED: Expanded Access for DNG64 for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast
- Conditions
- Pancreatic CancerOsteosarcomaMPNST (Malignant Peripheral Nerve Sheath Tumor)ChondrosarcomaSoft Tissue SarcomaChordomaSarcomaCarcinoma of Breast
- First Posted Date
- 2019-09-16
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Aveni Foundation
- Registration Number
- NCT04091295
- Locations
- 🇺🇸
Sarcoma Oncology Research Center, LLC, Santa Monica, California, United States
News
No news found